MANKIND PHARMA LTD
MANKIND PHARMA LTD, founded in 1995 and headquartered in New Delhi, India, is a leading pharmaceutical company with a strong presence in both acute and chronic therapeutic areas, operating 30 manufacturing facilities across India and serving 34 overseas destinations.
Company Overview
Mankind Pharma Ltd is a prominent player in the Pharmaceuticals industry, founded in 1995. The company operates with a large workforce of over 20,000 employees and has a team size of 13,020. With its headquarters located in New Delhi, India, Mankind Pharma emphasizes its commitment to 'Serving Life' by focusing on the affordability, accessibility, and quality of its products. The company has established a strong presence in both acute and chronic therapeutic areas.
Products and Specialties
Mankind Pharma Ltd offers a diverse range of products across various categories, including Pharmaceuticals, FMCG, OTC, Prescription Medicine, and Veterinary Medicine. Notable products include Manforce Condoms, AcneStar, Ring-Out, Preganews, Unwanted 72, Unwanted 21 Days, Gas-O-Fast, Kabzend, and Kaloree1. The company has a large product portfolio with over 1,000 marketed products and an additional 200 products under development.
Manufacturing and Facilities
The company operates 30 manufacturing facilities across India, with 21 of these facilities certified by WHO-GMP. Mankind Pharma has a total installed capacity of 43.5 billion units per annum across various dosage forms. It has a state-of-the-art manufacturing facility approved by the USFDA and has filed 60 abbreviated new drug applications (ANDAs) with the USFDA, along with 26 API drug master files (DMFs) in the USA.
Research and Development
Mankind Pharma Ltd has a dedicated R&D center with three units located in Gurugram, Haryana, and one in Mumbai. The R&D team comprises over 660 scientists, including more than 60 PhD holders. The company focuses on developing novel drug delivery systems, including dry-powder inhalers and metered-dose inhalers, and is also engaged in biotechnology projects aimed at creating biosimilars for anti-allergic and anti-cancer treatments.
Global Operations and CSR
Mankind Pharma Ltd operates in 34 overseas destinations, including regions in Asia, Africa, South-East Asia, Gulf countries, and CIS countries. The company has a strong commitment to corporate social responsibility (CSR), focusing on health, education, and livelihood enhancement to aid community well-being. Mankind Pharma has received multiple awards for manufacturing excellence and safety, including the International Safety Award from the British Safety Council.